Zymeworks Inc. Files 8-K: Material Agreement, Equity Sales
Ticker: ZYME · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1937653
| Field | Detail |
|---|---|
| Company | Zymeworks INC. (ZYME) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, filing
Related Tickers: ZYME
TL;DR
ZYME filed an 8-K for a material agreement & equity sales. Keep an eye on this.
AI Summary
On June 26, 2025, Zymeworks Inc. filed an 8-K report detailing an entry into a material definitive agreement. The filing also covers unregistered sales of equity securities and includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located at 108 Patriot Drive, Suite A, Middletown, DE 19709.
Why It Matters
This filing indicates Zymeworks Inc. has entered into a significant agreement and potentially issued new equity, which could impact its financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities, which can sometimes indicate financial strain or dilution for existing shareholders.
Key Numbers
- 001-41535 — SEC File Number (Identifies Zymeworks Inc.'s filing with the SEC.)
- 88-3099146 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Zymeworks Inc. (company) — Registrant
- June 26, 2025 (date) — Date of earliest event reported
- 108 Patriot Drive, Suite A, Middletown, Delaware 19709 (location) — Principal executive offices address
- Delaware (location) — State of incorporation
FAQ
What is the nature of the material definitive agreement entered into by Zymeworks Inc. on June 26, 2025?
The filing indicates an 'Entry into a Material Definitive Agreement' as an item information, but the specific details of the agreement are not provided in this excerpt.
What type of equity securities were sold unregistered by Zymeworks Inc.?
The filing lists 'Unregistered Sales of Equity Securities' as an item information, but the specific type and amount of securities are not detailed in this excerpt.
What are the key financial statements and exhibits included in this 8-K filing?
The filing mentions 'Financial Statements and Exhibits' as an item information, but the specific content of these documents is not detailed in this excerpt.
When was Zymeworks Inc. formerly known as Zymeworks Delaware Inc. and when did the name change occur?
Zymeworks Inc. was formerly known as Zymeworks Delaware Inc., and the date of the name change was July 12, 2022.
What is Zymeworks Inc.'s fiscal year end?
Zymeworks Inc.'s fiscal year end is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding Zymeworks Inc. (ZYME).